Cleared Traditional

Zfx Abutments (K231915) - FDA 510(k) Clearance

Class II Dental device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K231915 · Zfx GmbH - A Company of Zimvie · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2024
Decision
246d
Days
Class 2
Risk

K231915 is an FDA 510(k) clearance for the Zfx Abutments. Classified as Abutment, Implant, Dental, Endosseous within the NHA classification (a category for dental implant abutments and prosthetic components), Class II - Special Controls.

Submitted by Zfx GmbH - A Company of Zimvie (Dachau, DE). The FDA issued a Cleared decision on March 1, 2024 after a review of 246 days - an extended review cycle.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3630 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Zfx GmbH - A Company of Zimvie devices

Submission Details

510(k) Number K231915 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 29, 2023
Decision Date March 01, 2024
Days to Decision 246 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
119d slower than avg
Panel avg: 127d · This submission: 246d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NHA Abutment, Implant, Dental, Endosseous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3630
Definition To Be Used In Conjunction With An Endosseous Dental Implant Fixture To Aid In Prosthetic Rehabilitation.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Peers - NHA Abutment, Implant, Dental, Endosseous

All 318
Devices cleared under the same product code (NHA) and FDA review panel - the closest regulatory comparables to K231915.
LW Implant System – Abutment
K233167 · Ossvis Co., Ltd. · Mar 2024
Osteon Precision Milled Suprastructure
K233083 · Implant Solutions Pty Ltd (Aka Osteon Medical) · Mar 2024
DGA Abutment
K231210 · Modern Dental Laboratory (Dg) Co., Ltd. · Mar 2024
Oneday Implant Abutment
K231753 · Oneday Biotech Co., Ltd. · Feb 2024
TS Abutment System
K233194 · Osstem Implant Co., Ltd. · Feb 2024
NobelProcera Titanium ASC Abutment, Omnigrip Clinical Screw Titanium
K233208 · Nobel Biocare AB · Jan 2024